Tesamorelin research — FDA-approved GHRH analog studied for growth hormone secretion, visceral adipose tissue reduction, HIV lipodystrophy, cognitive function, and metabolic optimization. https://tesamorelin-research.com/ 2026-04-16T00:00:00Z Tesamorelin Research https://tesamorelin-research.com Eleventy Copyright 2026 Tesamorelin Research https://tesamorelin-research.com/articles/what-is-tesamorelin-ghrh-analog-research/ 2026-04-09T00:00:00Z 2026-01-15T00:00:00Z

Research review of Tesamorelin — the synthetic GHRH analog studied for growth hormone secretion and visceral adipose tissue reduction.

Tesamorelin Research https://tesamorelin-research.com/articles/growth-hormone-releasing-pathways-ghrh-vs-ghs-r/ 2026-04-09T00:00:00Z 2026-01-15T00:00:00Z

Two pathways, one outcome: how GHRH receptor and ghrelin receptor (GHS-R) signaling converge on growth hormone release, and why combining them matters.

Tesamorelin Research https://tesamorelin-research.com/articles/growth-hormone-secretagogues-complete-research-guide/ 2026-04-09T00:00:00Z 2026-01-15T00:00:00Z

Everything researchers need to know about GH secretagogues — Ipamorelin, CJC-1295, GHRP-6, Tesamorelin, and how they differ in mechanism and selectivity.

Tesamorelin Research https://tesamorelin-research.com/articles/future-of-metabolic-peptide-research/ 2026-04-09T00:00:00Z 2026-01-15T00:00:00Z

Where metabolic peptide research is heading — oral formulations, multi-receptor agonists, mitochondrial targets, and the convergence of obesity and aging science.

Tesamorelin Research https://tesamorelin-research.com/articles/ipamorelin-selective-growth-hormone-secretagogue/ 2026-04-09T00:00:00Z 2026-01-15T00:00:00Z

Research review of Ipamorelin — the highly selective GHS-R agonist studied for growth hormone release without significant effects on cortisol, prolactin, or appetite.

Tesamorelin Research